These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4042521)

  • 21. Analytical methods for the determination of sulindac and metabolites in plasma, urine, bile, and gastric fluid by liquid chromatography using ultraviolet detection.
    Musson DG; Vincek WC; Constanzer ML; Detty TE
    J Pharm Sci; 1984 Sep; 73(9):1270-3. PubMed ID: 6491950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal metabolism of sulindac: functional implications.
    Miller MJ; Bednar MM; McGiff JC
    J Pharmacol Exp Ther; 1984 Nov; 231(2):449-56. PubMed ID: 6436473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa.
    Graham DY; Smith JL; Holmes GI; Davies RO
    Clin Pharmacol Ther; 1985 Jul; 38(1):65-70. PubMed ID: 3874038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
    Duggan DE; Hooke KF; Hwang SS
    Drug Metab Dispos; 1980; 8(4):241-6. PubMed ID: 6105058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the gut flora in the reduction of sulfinpyrazone in humans.
    Strong HA; Oates J; Sembi J; Renwick AG; George CF
    J Pharmacol Exp Ther; 1984 Sep; 230(3):726-32. PubMed ID: 6470977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. II. Differential effects on the biliary excretion.
    Lin JH; Yeh KC; Duggan DE
    Drug Metab Dispos; 1985; 13(5):608-13. PubMed ID: 2865112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro metabolism of sulindac and sulindac sulfide: enzymatic formation of sulfoxide and sulfone.
    Kitamura S; Tatsumi K
    Jpn J Pharmacol; 1982 Oct; 32(5):833-8. PubMed ID: 7176218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liquid chromatographic determination of sulindac and metabolites in serum.
    Clark CR; McMillian CL; Hoke JF; Campagna KD; Ravis WR
    J Chromatogr Sci; 1987 Jun; 25(6):247-51. PubMed ID: 3611280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental transfer of sulindac and its active sulfide metabolite in humans.
    Kramer WB; Saade G; Ou CN; Rognerud C; Dorman K; Mayes M; Moise KJ
    Am J Obstet Gynecol; 1995 Mar; 172(3):886-90. PubMed ID: 7892880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The disposition of sulindac.
    Duggan DE; Hare LE; Ditzler CA; Lei BW; Kwan KC
    Clin Pharmacol Ther; 1977 Mar; 21(3):326-35. PubMed ID: 300048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of single-nucleotide polymorphisms of FMO3 and FMO6 genes on pharmacokinetic characteristics of sulindac sulfide in premature labor.
    Park S; Lee NR; Lee KE; Park JY; Kim YJ; Gwak HS
    Drug Metab Dispos; 2014 Jan; 42(1):40-3. PubMed ID: 24173915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulindac oxidation/reduction by microbial cultures; microbial models of mammalian metabolism.
    Davis PJ; Guenthner LE
    Xenobiotica; 1985 Oct; 15(10):845-57. PubMed ID: 4072250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-performance liquid chromatography of sulindac and its sulphone and sulphide metabolites in plasma.
    Grgurinovich N
    J Chromatogr; 1987 Feb; 414(1):211-6. PubMed ID: 3571386
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of sulindac and its metabolites on acute stress-induced gastric ulcers in rats.
    Glavin GB; Sitar DS
    Toxicol Appl Pharmacol; 1986 Apr; 83(2):386-9. PubMed ID: 3961821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of sulindac and its metabolites in human serum by reversed-phase high-performance liquid chromatography using on-line post-column ultraviolet irradiation and fluorescence detection.
    Siluveru M; Stewart JT
    J Chromatogr B Biomed Appl; 1995 Nov; 673(1):91-6. PubMed ID: 8925079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of sulindac with other cyclooxygenase inhibitors on prostaglandin excretion and renal function in normal and chronic bile duct-ligated dogs and swine.
    Zambraski EJ; Chremos AN; Dunn MJ
    J Pharmacol Exp Ther; 1984 Mar; 228(3):560-6. PubMed ID: 6423807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of Optimized Human Fecal Material in Simulating the Bacterial Degradation of Sulindac and Sulfinpyrazone in the Lower Intestine.
    Kostantini C; Arora S; Söderlind E; Ceulemans J; Reppas C; Vertzoni M
    Mol Pharm; 2022 Jul; 19(7):2542-2548. PubMed ID: 35729720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfoxide reduction. In vitro reduction of sulindac by rat hepatic cytosolic enzymes.
    Ratnayake JH; Hanna PE; Anders MW; Duggan DE
    Drug Metab Dispos; 1981; 9(2):85-7. PubMed ID: 6113122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Placental transfer of sulindac, sulindac sulfide, and indomethacin in a human placental perfusion model.
    Lampela ES; Nuutinen LH; Ala-Kokko TI; Parikka RM; Laitinen RS; Jouppila PI; Vähäkangas KH
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):174-80. PubMed ID: 9914600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do normal plasma neurotensin concentrations increase ileal output?
    MacKay AD; Jones HW; Gough A; Peart SW; Freeman TC; Springer CJ; Calam J
    Regul Pept; 1990 Mar; 27(3):299-306. PubMed ID: 2326501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.